Trial Profile
A Single Center, Phase I, Double-blind, Placebo-controlled Evaluation of the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Deferiprone Administered by Intravenous Infusion to Healthy Male and Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary) ; Deferiprone (Primary)
- Indications Friedreich's ataxia; Iron overload; Kidney disorders; Pantothenate kinase-associated neurodegeneration
- Focus Adverse reactions; Pharmacokinetics
- Sponsors ApoPharma
- 18 Mar 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 27 Nov 2013 New trial record